740
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Seroprevalence survey for Varicella among healthcare workers and medical students in Italy

, ORCID Icon, , , &
Pages 372-376 | Received 29 Feb 2020, Accepted 15 May 2020, Published online: 09 Jul 2020

References

  • Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations Rep. 2007 Jun 22;56(RR–4):1–40.
  • Arvin AM. Varicella-zoster virus: overview and clinical manifestations. Semin Dermatol. 1996 Jun;15(2 Suppl 1):4–7.
  • Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996 Sep;10(3):571–81.
  • Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, Nozad B, Mirinaviciute G, Flem E, Souverain A, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017 May 18;17(1):353.
  • Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15:645–57.
  • EUVAC.NET. Surveillance of Varicella and Herpes Zoster in Europe2010.
  • Eurostat. Statistical office of the European communities.
  • Sauboin C, Holl K, Bonanni P, Gershon AA, Benninghoff, B, Carryn S, Burgess MA, Wutzler P. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting. BMC Infect Dis. 2019 Feb 6;19(1):126.
  • Lo Presti C, Curti C, Montana M, Bornet C, Chickenpox: VP. An update. Med Mal Infect. 2019 Feb;49(1):1–8.
  • CDC. Epidemiology and prevention of vaccine-preventable diseases. 2015.
  • Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, et al. Varicella zoster virus infection. Nature reviews. Dis Primers. Jul 2 2015. 1: 15016.
  • Rieck T, Feig M, An der Heiden M, Siedler A, Wichmann O. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 2017 Apr 27;22(17): 30521.
  • Conferenza Stato-Regioni. Piano nazionale prevenzione vaccinale2017–2019. 2017 Feb 18.
  • Decreto-legge 7 giugno 2017, n. 73. Disposizioni urgenti in materia di prevenzione vaccinale, di malattie infettive e di controversie relative alla somministrazione di farmaci. (17A05515) (GU SerieGenerale n.182 del 05- 08-2017)
  • Ministero della Salute. Circolare n. 25233. 16 Agosto 2018.
  • De Donno A, Kuhdari P, Guido M, De Donno A, Kuhdari P, Guido M, Rota MC, Bella A, Brignole G, Lupi S, et al. Study Group on seroepidemiology. Has VZV epidemiology changed in Italy? Results of a seroprevalence study. Hum Vaccin Immunother. 2017 Feb, 13(2): 385–90.
  • Gabutti G, Rota MC, Guido M, De Donno A, Bella A, Ciofi degli Atti ML, Crovari P, Seroepidemiology Group. The epidemiology of Varicella Zoster Virus infection in Italy. BMC Public Health. Oct 27 2008. 8: 372.
  • Koivisto K, Puhakka L, Lappalainen M, Blomqvist S, Saxen H, Nieminen T. Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015. Vaccine. 2017 Mar 14;35(12):1608–14.
  • Ferraro M, Morucci L, Coppeta L, De Carolis G, Pietroiusti A, Franco E, Magrini A. Managing the risk of bacterial meningitis among healthcare workers. Occup Med (Chic Ill). 2019 Apr 13;69(2):113–17.
  • Lopez AS, Burnett-Hartman A, Nambiar R, Ritz L, Owens P, Loparev VN, Guris D, Schmid DS. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis. 2008 Mar 1;197(5):646–53.
  • Haiduven-Griffiths D, Fecko H. Varicella in hospital personnel: a challenge for the infection control practitioner. Am J Infect Control. 1987 Oct;15(5):207–11.
  • Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clinical infectious diseases: an official publication of the infectious diseases society of America. 2002 Mar 15;34(6): 774–79.
  • Squeri R, Genovese C, Trimarchi G, MAR P, La FV. An evaluation of attitude toward vaccines among healthcare workers of a university hospital in Southern Italy. Annali di igiene:medicina preventiva e di comunità, 2017 Nov-Dec; 29(6):595–606. doi:10.7416/ai.2017.2188.
  • Saiman L, LaRussa P, Steinberg SP, Zhou J, Baron K, Whittier S, Della-Latta P, Gershon AA. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect Control Hosp Epidemiol. 2001 May, 22(5): 279–83.
  • Gorny AW, Mittal C, Saw S, Venkatachalam I, Fisher DA, Tambyah PA. Varicella seroprevalence in healthcare workers in a tertiary hospital: an audit of cross-sectional data. BMC Res Notes. 2015;8:664. Published 2015 Nov 10. doi:10.1186/s13104-015-1656-0.
  • Coppeta L, Pietroiusti A, Lieto P, Ferraro M, Grelli S, Stillo M, Magrini Al. Measles immunity in an Italian teaching hospital. Occup Med (Chic Ill). 2019 Apr 13;69(2):143–45.
  • Coppeta L, Balbi O, Baldi S, Pietroiusti A, Magrini A. Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among health care workers. Hum Vaccin Immunother. 2019;15:1135–38.
  • Coppeta L, Morucci L, Pietroiusti A, Magrini A. Cost-effectiveness of workplace vaccination against measles. Hum Vaccin Immunother. 2019;15:2847–50.
  • Alp E, Cevahir F, Gokahmetoglu S, Demiraslan H, Doganay M. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: what do we save? J Infect Public Health. 2012 Apr;5(2):127–32.
  • Baracco GJ, Eisert S, Saavedra S, Hirsch P, Marin M, Ortega-Sanchez IR. Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel. Am J Infect Control. 2015 Oct 1;43(10):1053–60.
  • Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control. 2003 May, 31(3): 157–62.
  • Baer G, Bonhoeffer J, Schaad UB, Heininger U. Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine. 2005 Mar 14;23(16):2016–20.
  • Wutzler P, Bonanni P, Burgess M, Gershon A, Sáfadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16:833–43.
  • Weber DJ, Rutala WA, Hamilton H. Prevention and control of varicella-zoster infections in healthcare facilities. Infect Control Hosp Epidemiol. 1996;17:694–705.
  • Saidel-Odes L, Borer A, Riesenberg K, Frenkel A, Sherlis R, Bouhnick L, Schlaeffer F. An outbreak of varicella in staff nurses exposed to a patient with localized herpes zoster. Scand J Infect Dis. 2010;42(8):620–22.
  • Bloch KC, Johnson JG. Varicella zoster virus transmission in the vaccine era: unmasking the role of herpes zoster. J Infect Dis. 2012;205:1331–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.